Abacavir - CISMeF

Preferred Label : Abacavir;

MeSH definition : A carbocyclic nucleoside reverse transcriptase inhibitor with potent and selective anti-HIV activity.;

MeSH synonym : (-)-cis-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol; (1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol; Avacavir;

MeSH hyponym : Abacavir Sulphate; (1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol succinate (1:1) (salt); 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, hydrochloride, hydrate (1:1:1), (1S,4R)-; ( )-Abacavir Sulfate; (1R,4S)-Abacavir Sulfate; 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1R,4S)-, sulfate (2:1); Abacavir Sulfate, (1R,4S)-; ((1R,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-cyclopent-2-enyl)methanol; Abacavir, trans-; Abacavir, Trans-, ( -)-; 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S,4R)-, rel-, sulfate (2:1); Abacavir Sulfate Racemic; Abacavir Sulfate, ( -)-; ((1R,4S)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-enyl)methanol; Abacavir enantiomer; abacavir, ( )-; Abacavir, (1R,4S)-; trans-Abacavir R,R-; DRG 0257; DRG0257;

MeSH Related Number : 0903H757IU; 1PPL256S5A; 40FH6D8CHK; 6BVN3YCO99; GZP7A66C3C; J220T4J9Q2; PMA9EH08PM; X9A7099R51;

UNII : WR2TIP26VS;

Details

Origin ID

D000099227;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- (+)-abacavir [MeSH concept]
- (+-)-abacavir sulfate [MeSH concept]
- (1R,4R)-abacavir [MeSH concept]
- 1592U89 [MeSH concept]
- Abacavir [MeSH concept]
- Abamune [MeSH concept]
- DRG-0257 [MeSH concept]
- abacavir hydrochloride monohydrate [MeSH concept]
- abacavir succinate [MeSH concept]
- abacavir sulfate [MeSH concept]
- abacavir sulfate, (+)- [MeSH concept]
- trans-abacavir [MeSH concept]
- ziagen [MeSH concept]
Related MeSH Supplementary Concept(s)
- abacavir 5'-monophosphate [MeSH Supplementary Concept]
- abacavir hydroxyacetate [MeSH Supplementary Concept]
- abacavir, dolutegravir, and lamivudine drug combination [MeSH Supplementary Concept]
- abacavir, lamivudine drug combination [MeSH Supplementary Concept]
- abacavir, lamivudine, and zidovudine drug combination [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients